EE477 Budgetary Impact Analysis of Alteplase - Recombinant Tissue Plasminogen Activator (RTPA) - As a Thrombolytic Treatment for Acute Ischemic Stroke in Colombia
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.725
https://www.valueinhealthjournal.com/article/S1098-3015(22)00926-3/fulltext
Section Title :
Section Order :
10651
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00926-3&doi=10.1016/j.jval.2022.04.725